Credit Suisse Ag Omeros Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$2.48 - $5.22 $3,968 - $8,352	-1,600 Reduced 5.55%	27,236 $126,000
Q4 2022 Feb 13, 2023	SELL	$1.75 - $3.96 $54,482 - $123,286	-31,133 Reduced 51.92%	28,836 $65,000
Q3 2022 Nov 10, 2022	BUY	$3.09 - $7.46 $78,424 - $189,334	25,380 Added 73.38%	59,969 $189,000
Q2 2022 Aug 12, 2022	SELL	$1.92 - $6.28 $363,121 - $1.19 Million	-189,126 Reduced 84.54%	34,589 $95,000
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $239,826 - $340,581	-47,303 Reduced 17.45%	223,715 $1.34 Million
Q4 2021 Feb 14, 2022	SELL	$5.67 - $8.54 $247,699 - $373,078	-43,686 Reduced 13.88%	271,018 $1.74 Million
Q3 2021 Nov 12, 2021	BUY	$13.4 - $16.3 $385,678 - $469,146	28,782 Added 10.07%	314,704 $4.34 Million
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $308,196 - $398,095	20,810 Added 7.85%	285,922 $4.24 Million
Q1 2021 May 14, 2021	SELL	$14.52 - $23.53 $475,878 - $771,172	-32,774 Reduced 11.0%	265,112 $4.72 Million
Q4 2020 Feb 12, 2021	BUY	$10.14 - $15.19 $408,662 - $612,187	40,302 Added 15.65%	297,886 $4.26 Million
Q3 2020 Nov 13, 2020	BUY	$9.57 - $21.32 $114,801 - $255,754	11,996 Added 4.88%	257,584 $2.6 Million
Q2 2020 Aug 12, 2020	BUY	$12.21 - $16.99 $223,455 - $310,933	18,301 Added 8.05%	245,588 $3.62 Million
Q1 2020 May 13, 2020	BUY	$9.03 - $19.72 $120,108 - $262,295	13,301 Added 6.22%	227,287 $3.04 Million
Q4 2019 Feb 12, 2020	BUY	$13.01 - $17.15 $147,780 - $194,806	11,359 Added 5.61%	213,986 $3.02 Million
Q3 2019 Nov 12, 2019	BUY	$14.55 - $20.56 $139,054 - $196,491	9,557 Added 4.95%	202,627 $3.31 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.62 $197,805 - $258,728	13,187 Added 7.33%	193,070 $3.03 Million
Q1 2019 May 14, 2019	SELL	$11.65 - $17.72 $257,371 - $391,470	-22,092 Reduced 10.94%	179,883 $3.12 Million
Q4 2018 Feb 13, 2019	BUY	$10.72 - $16.73 $1.76 Million - $2.74 Million	163,981 Added 431.6%	201,975 $2.25 Million
Q3 2018 Nov 13, 2018	SELL	$17.73 - $26.69 $221,093 - $332,824	-12,470 Reduced 24.71%	37,994 $927,000
Q2 2018 Aug 14, 2018	SELL	$10.79 - $24.44 $42,577 - $96,440	-3,946 Reduced 7.25%	50,464 $916,000
Q1 2018 May 15, 2018	BUY	$9.0 - $20.16 $7,362 - $16,490	818 Added 1.53%	54,410 $607,000
Q4 2017 Feb 14, 2018	BUY	$13.26 - $22.86 $78,472 - $135,285	5,918 Added 12.41%	53,592 $1.04 Million
Q3 2017 Nov 14, 2017	BUY	$19.76 - $24.9 $288,041 - $362,967	14,577 Added 44.04%	47,674 $1.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	33,097	33,097 $659,000

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

Ingalls & Snyder LLC New York, NY

4.54M
Shares

$55.2 Million
0.7% of portfolio
Black Rock Inc. New York, NY

4.1M
Shares

$49.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.26M
Shares

$39.6 Million
0.0% of portfolio
Stifel Financial Corp St. Louis, MO

1.9M
Shares

$23.1 Million
0.01% of portfolio
D. E. Shaw & Co., Inc. New York, NY

1.61M
Shares

$19.5 Million
0.01% of portfolio

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account